The return to financial health of Ras Al-Khaimah (RAK)’s Gulf Pharmaceutical Industries (Julphar) is likely to be aided by a contract to produce the Covid-19 vaccine developed by Sinopharm China National Biotec Group and Abu Dhabi-based Group 42. The latter is linked to national security adviser Sheikh Tahnoun Bin Zayed.
Subscribe to Gulf States Newsletter
Sign up for an account to gain:
Gulf States Newsletter is a brand of
